KYG7487R1002 - Common Stock
REGENCELL BIOSCIENCE HOLDING
NASDAQ:RGC (9/6/2024, 8:00:02 PM)
6.69
-0.52 (-7.16%)
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
REGENCELL BIOSCIENCE HOLDING
11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay
Hong Kong 37918
P: 85221550823
CEO: Yat-Gai Au
Employees: 12
Website: https://www.regencellbioscience.com/
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.
Here you can normally see the latest stock twits on RGC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: